Jms Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 15-11-2024
- Paid Up Capital ₹ 2.00 M
as on 15-11-2024
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.04 Cr
as on 15-11-2024
- Revenue 26.90%
(FY 2023)
- Profit 473.64%
(FY 2023)
- Ebitda 677.57%
(FY 2023)
- Net Worth 54.10%
(FY 2023)
- Total Assets 32.48%
(FY 2023)
About Jms Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.04 Cr.
Purnima Kulkarni, Naveen Doddamani, Varun Kulkarni, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999KA2012PTC063045
- Company No.
063045
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Mar 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Dharwad, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Jms Biotech Private Limited offer?
Jms Biotech Private Limited offers a wide range of products and services, including Environment Protection Services, Environmental Management Services, Fountains & Water Features, Water Fountain, Marine Tools & Equipments, Marine Equipments, Wastewater Treatment Services, Water Treatment Services, Floating Barrier, Waste Management & Control Services.
Who are the key members and board of directors at Jms Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Purnima Kulkarni  | Director | 20-Oct-2012 | Current |
| Naveen Doddamani | Director | 30-Sep-2015 | Current |
| Varun Kulkarni | Director | 02-Nov-2017 | Current |
| Prakash Kulkarni | Director | 14-Mar-2012 | Current |
Financial Performance of Jms Biotech.
Jms Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.9% increase. The company also saw a substantial improvement in profitability, with a 473.64% increase in profit. The company's net worth Soared by an impressive increase of 54.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jms Biotech?
In 2023, Jms Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jalavahini Management Services Private LimitedActive 21 years 21 daysPrakash Kulkarni is a mutual person
Mysore Water Services Private LimitedActive 15 years 2 monthsPurnima Kulkarni, Naveen Doddamani and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 04 Nov 2022 | ₹1.50 M | Open |
Hdfc Bank Limited Creation Date: 17 Jun 2022 | ₹2.20 M | Open |
Axis Bank Limited Creation Date: 18 Dec 2021 | ₹6.70 M | Open |
How Many Employees Work at Jms Biotech?
Unlock and access historical data on people associated with Jms Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jms Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jms Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
